PAG
STLN

Private Advisor Group’s Starling Oncology STLN Stock Holding History

Private Advisor Group’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249K Sell
45,850
-48,320
-51% -$203K ﹤0.01% 2216
2026
Q1 		$289K Buy
94,170
+31,948
+51% +$98K ﹤0.01% 2204
2025
Q4 		$222K Sell
62,222
-6,700
-10% -$24.8K ﹤0.01% 2341
2025
Q3 		$241K Buy
+68,922
New +$236K ﹤0.01% 2223

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Private Advisor Group's STLN Position: Q2 2026 in Review

Private Advisor Group reduced its Starling Oncology (STLN) stake by 51% in Q2 2026, selling an estimated $203K and leaving 45,850 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #2216.

Private Advisor Group first reported a position in STLN in Q3 2025 and has held it in 4 quarters since. The position peaked at $289K in Q1 2026. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Private Advisor Group held 45,850 shares of Starling Oncology worth $249K as of Q2 2026.
  • Private Advisor Group sold 48,320 Starling Oncology shares in Q2 2026, an estimated $203K.
  • Starling Oncology made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #2216 holding.
  • Private Advisor Group first reported a position in Starling Oncology in Q3 2025 and has held it in 4 quarters since.
  • Private Advisor Group's Starling Oncology position peaked at $289K in Q1 2026.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.